BioSpace News Archive

Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced that it will release its second quarter 2022 financial results on Thursday, August 11, 2022.

Umoja Biopharma, Inc., an immuno-oncology company pioneering off-the-shelf, integrated therapeutics that reprogram immune cells in vivo to treat patients with solid and hematologic malignancies, announced new data at the 2022 iPSC Manufacturing Summit held in Boston, Mass.

Eargo, Inc., a medical device company on a mission to improve hearing health, announced it will release financial results for the second quarter 2022 after market close on August 8, 2022.

Coherus BioSciences, Inc., announced that its second quarter 2022 financial results will be released after market close on Thursday, August 4th, 2022.

Aziyo Biologics, Inc., a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced that it will release second quarter 2022 financial results after market close on Thursday, August 11, 2022.

Minerva Surgical, Inc., a woman’s health company focused on the treatment of Abnormal Uterine Bleeding, announced that it will release its second quarter 2022 financial results on Tuesday, August 9, 2022.

Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, announced plans to present at the UBS Genomics 2.0 and MedTech Innovations Summit in Laguna Beach, California.

Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and multiomics technologies to empower researchers and clinicians, announced that it will report financial results for the second quarter 2022 after the market close on Tuesday, August 9, 2022.

Ultragenyx Pharmaceutical Inc. reported its financial results for the quarter ended June 30, 2022 and provided a corporate update for the year.

Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced that the Company will host a conference call and webcast on August 8, 2022 at 4:30 pm ET to provide a business update and report second quarter 2022 financial results.